Melatonin: functions and ligands
•Pathways controlling melatonin secretion are complex.•There are various causes of melatonin disturbance.•Evaluation of melatonin secretion clinically requires long time treatment.•Beneficial effect, at low dosages only, at high dosage results are diverse.•Melatonin mediates function through, antiox...
Gespeichert in:
Veröffentlicht in: | Drug discovery today 2014-09, Vol.19 (9), p.1410-1418 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Pathways controlling melatonin secretion are complex.•There are various causes of melatonin disturbance.•Evaluation of melatonin secretion clinically requires long time treatment.•Beneficial effect, at low dosages only, at high dosage results are diverse.•Melatonin mediates function through, antioxidant action in most of disorders.
Melatonin is a chronobiotic substance that acts as synchronizer by stabilizing bodily rhythms. Its synthesis occurs in various locations throughout the body, including the pineal gland, skin, lymphocytes and gastrointestinal tract (GIT). Its synthesis and secretion is controlled by light and dark conditions, whereby light decreases and darkness increases its production. Thus, melatonin is also known as the ‘hormone of darkness’. Melatonin and analogs that bind to the melatonin receptors are important because of their role in the management of depression, insomnia, epilepsy, Alzheimer's disease (AD), diabetes, obesity, alopecia, migraine, cancer, and immune and cardiac disorders. In this review, we discuss the mechanism of action of melatonin in these disorders, which could aid in the design of novel melatonin receptor ligands. |
---|---|
ISSN: | 1359-6446 1878-5832 |
DOI: | 10.1016/j.drudis.2014.04.014 |